Author:
Arroyo-Andrés J.,Arteche-López A.R.,González-Granado I.,Postigo Llorente C.
Funder
European Commission
Instituto de Salud Carlos III
Reference6 articles.
1. Aicardi–Goutières syndrome and the type I interferonopathies;Crow;Nat Rev Immunol,2015
2. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1;Crow;Am J Med Genet A,2015
3. Degos disease: a C5b-9/interferon-α-mediated endotheliopathy syndrome;Magro;Am J Clin Pathol,2011
4. Chilblains as a diagnostic sign of Aicardi–Goutières syndrome;Abdel-Salam;Neuropediatrics,2010
5. Commentary on “Catatonia in a patient with Aicardi–Goutières syndrome efficiently treated with immunoadsorption”;Varesio;Schizophr Res,2020